iNova Pharmaceuticals has appointed Clemenger BBDO Sydney to handle its portfolio of brands that include cough, cold & flu and throat brands Duro-Tuss, Difflam and the Dermaveen therapeutic skin care range.
The appointment expands its existing relationship with the agency which was appointed to work on the Demazin brand at the start of the year.
“It was a key priority for iNova to work with a strategic partner agency that could help us get under the skin of our consumers to make our brands stickier and more distinctive in people’s minds," iNova Pharmaceuticals marketing director – consumer healthcare Steve Maidment says.
"Pete and his team have quickly demonstrated that they really ‘get’ our brands and importantly have shown they have the passion and expertise to deliver the transformational creativity we are seeking."
Clemenger BBDO Sydney CEO Pete Bosilkovski says the agency is "thrilled" to deepen its engagement and involvement with the iNova team.
“We love the thirst for innovation and passion the team at iNova have to disrupt the category," Bosilkovski says.
"We’ve relished the opportunity to work on the iconic Demazin brand and we look forward to building on the terrific partnership we have built with the team at iNova to deliver more great work together."
Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au
Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day.